Gelteq LTD F-1 registration statements

Gelteq Limited has filed an amendment to its F-1 registration statement to allow Lincoln Park Capital Fund, LLC to resell up to 4,000,000 ordinary shares, following recent capital raises and debt conversions.

Gelteq Limited has filed an F-1 registration statement for the resale of up to 4,000,000 ordinary shares by Lincoln Park Capital Fund, LLC, aiming to secure up to $12 million in gross proceeds to fund its R&D and operations amidst a history of significant operating losses and a going concern doubt.

Gelteq Limited has filed an amendment to its Form F-1 registration statement with the SEC, primarily to include certain exhibits related to its proposed initial public offering.

Gelteq Limited is seeking to list on the Nasdaq Capital Market through an initial public offering of 1,300,000 Ordinary Shares and a concurrent resale of 1,749,243 Ordinary Shares by existing shareholders.

Gelteq Limited, an Australian clinical and science-based company, files for a U.S. IPO aiming to raise $6.5 million while highlighting a research services agreement with Monash University.

Gelteq Limited, an Australian company focused on gel-based delivery solutions, is seeking to raise capital through a U.S. IPO to advance its technology and expand its market reach.